Editorial Policy and Philosophy

Article intention: Articles are intended for informational purposes only and should not be used as the basis of patient treatment. All opinions expressed by authors and quoted sources are their own and do not necessarily reflect the opinions of the editors, publisher or editorial boards of SLACK Incorporated. The acceptance of advertising in no way implies endorsement by the editors, publishers or Editorial Advisory Board members of SLACK Incorporated. Nephrology News & Issues does not publish articles on the basis of advertising support and purposely does not put editorial content next to an unintentionally related advertisement. However, there are unavoidable occasions when this may happen. This in no way implies endorsement or quid pro quo.

Article review process: All articles in Nephrology News & Issues are reviewed by the study’s researchers, with additional guidance provided by the publication’s Editorial Advisory Board and other medical professionals who work in the study of nephrology. All staff-written news reports are sent to quoted sources for verification of medial accuracy prior to publication. Letters and other unsolicited material are assumed to be intended for publication and are subject to review and editing. Unsolicited physician-written and other expert-written original articles are encouraged but also are subject to the editorial process.

Because Nephrology News & Issues reports on emerging technologies, techniques and medical therapies, some reports may discuss drug and device applications that either are not approved by the appropriate regulatory body and/or the Food and Drug Administration or are not considered to be within the standard practice of medicine. In lieu of placing a trademark symbol at each occurrence of a trademark name, we acknowledge here that the omission is due to the editorial nature of the publication and with no intention of trademark infringement.

Dateline policy: In the interest of accountability and transparency in its reporting practices, Nephrology News & Issues includes datelines with articles only if the reporter attended the presentation of the information on which they reported. As a prerequisite for publication, all authors and quoted sources are asked to disclose fully and specifically any direct financial interest in products mentioned in articles, as well as their status as paid consultants or employees for any companies mentioned.

Contact any Editorial Advisory Board Member at Nephrology News & Issues, 6900 Grove Rd., Thorofare, NJ 08086; 856-848-1000 or 800-257-8290, fax: 856-853-5991, email: nephrology@healio.com.

Advertising: Though the Nephrology News & Issues website is supported by advertising, its acceptance of advertising in no way implies endorsement by the editors, publisher or editorial boards. All advertisements appearing on the Nephrology News & Issues website are placed in fixed positions that are predetermined. The positioning of advertisements is not related to editorial content or known in advance of an article's publication; any appearance otherwise is simply coincidence.